Imbalanced mucosal microcirculation in the remission stage of ulcerative colitis using probe-based confocal laser

Yu Tian1, Yue Zheng1, Guigen Teng1

  • 1Gastroenterology Department of Peking University First Hospital, Beijing, China.

Insights

Confocal Laser Endomicroscopy revealed altered colonic microcirculation in ulcerative colitis (UC) patients. Decreased capillary density and distinct blood flow patterns in UC indicate potential for monitoring disease activity and healing.

Area of Science:

  • Gastroenterology and Hepatology
  • Medical Imaging
  • Microcirculation Research

Background:

  • Microcirculatory disturbances are implicated in Inflammatory Bowel Disease (IBD) pathogenesis.
  • Confocal Laser Endomicroscopy (CLE) enables in-vivo visualization of colonic mucosal microcirculation.
  • Limited studies have explored microcirculatory changes in IBD using advanced imaging.

Purpose of the Study:

  • To investigate and compare colonic microcirculation parameters between ulcerative colitis (UC) patients in remission and healthy controls.
  • To analyze the relationship between specific microcirculatory blood flow patterns and disease recurrence in UC patients.
  • To assess the utility of probe-based Confocal Laser Endomicroscopy (pCLE) in evaluating mucosal healing indicators.

Main Methods:

  • Retrospective analysis of 7 UC patients in clinical remission and 7 healthy subjects undergoing pCLE (2014-2016).
  • pCLE examination of ascending, transverse/descending, and sigmoid colon segments.
  • Quantification of Mean Vessel Diameter (MVD), Diameter Standard Deviation (DSD), Functional Capillary Density-long (FCDL), and Functional Capillary Density-area (FCDA) using specialized software.
  • Classification of blood flow patterns into Around (A), Cobweb (C), and Deficiency (D) types for correlation with recurrence.

Main Results:

  • UC patients exhibited significantly increased DSD and decreased FCDA compared to healthy subjects (P < 0.01).
  • No significant differences were observed in MVD and FCDL between the groups.
  • Healthy subjects showed Type A (66.67%) and Type C (33.33%) blood flow; UC patients predominantly showed Type C (71.3%) and Type D (14.29%) (P < 0.01).
  • Type D blood flow was associated with a shorter recurrence interval in UC patients.

Conclusions:

  • Local mucosal capillary density is reduced in UC patients, particularly in inflamed segments.
  • The identified mucosal blood flow patterns (A, C, D) serve as potential indicators of mucosal healing in UC.
  • pCLE offers valuable insights into microcirculatory alterations relevant to UC pathogenesis and monitoring.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
934
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
476
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.2K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.4K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.1K